Pharmacognostical and physicochemical standardization of Mutrakrichantak churna (An ayurvedic herbal formulation)
BIOCHEMICAL AND CELLULAR ARCHIVES · 17.11.2025 · 26 (1) · 565-576
DOI: 10.51470/bca.2026.26.1.565 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIOCHEMICAL AND CELLULAR ARCHIVES, online erschienen am 24.11.2025. Verfasst von Neha Pathak und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Mutrakrichantak Churna is an Ayurvedic polyherbal formulation comprising Crateva nurvala, Phyllanthus niruri, Tribulus terrestris and Andrographis paniculata, traditionally prescribed for urinary and renal disorders. Scientific validation through standardization is essential to ensure its quality, safety, and reproducibility. This study aimed to establish pharmacognostical, physicochemical, phytochemical and safety parameters for Mutrakrichantak Churna as per WHO and Ayurvedic Pharmacopoeia guidelines. Raw drugs were authenticated through morphological and fluorescence analysis. Organoleptic features were documented, and physicochemical parameters including LOD, ash values, extractive values, and pH were evaluated. Phytochemical screening was conducted to confirm the presence of bioactive groups. Powder flow properties were assessed by bulk density, tapped density, angle of repose, Hausner ratio and Carr’s index. Safety was ensured through ICP–MS based heavy metal detection and microbial load analysis. The organoleptic and fluorescence properties of the formulation corresponded to the pharmacopoeia. Physicochemical Inspection showed a satisfactory moisture, ash and extractive values with close-to-neutral pH which are not only pure but also stable. The screening of phytochemicals revealed phenolics, flavonoids, alkaloids and saponins, which explain its nephroprotective and diuretic effects. The powder property examination indicated that it could flow and compress well. The level of heavy metal was within acceptable boundaries and the microbial examination showed that there were no pathogens. Together with physicochemical and phytochemical analysis, the traditional claims of the formulation are supported through integrated pharmacogenostic analysis to verify the quality and safety profile of the formulation. The observed phytochemical interactions highlight the therapeutic role of Mutrakrichantak Churna in urinary and renal diseases, and this stresses its use as a complement in the Ayurvedic pharmacology canon. In conclusion, the results provide standardization parameters of baseline values of Mutrakrichantak Churna, which is an effective basis of quality control and endorses the therapeutic claims of diverse Mutrakrichantak Churna. The outcomes also introduce the path to many sophisticated pharmacological validation and clinical review.
Zitieren
APA
Pathak, N., & Kannojia, P. (2025). Pharmacognostical and physicochemical standardization of Mutrakrichantak churna (An ayurvedic herbal formulation). BIOCHEMICAL AND CELLULAR ARCHIVES, 26(1), 565-576. https://doi.org/10.51470/bca.2026.26.1.565
Vancouver
Pathak N, Kannojia P. Pharmacognostical and physicochemical standardization of Mutrakrichantak churna (An ayurvedic herbal formulation). BIOCHEMICAL AND CELLULAR ARCHIVES. 2025;26(1):565-576. doi:10.51470/bca.2026.26.1.565
BibTeX
@article{Pathak2025,
author = {Pathak, Neha and Kannojia, Pushpendra},
title = {Pharmacognostical and physicochemical standardization of Mutrakrichantak churna (An ayurvedic herbal formulation)},
journal = {BIOCHEMICAL AND CELLULAR ARCHIVES},
year = {2025},
volume = {26},
number = {1},
pages = {565--576},
doi = {10.51470/bca.2026.26.1.565}
}
EUVIMED